Cite
FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients.
MLA
Hagedorn, Martin, et al. “FBXW7/HCDC4 Controls Glioma Cell Proliferation in Vitro and Is a Prognostic Marker for Survival in Glioblastoma Patients.” Cell Division, vol. 2, Feb. 2007, p. 9. EBSCOhost, https://doi.org/10.1186/1747-1028-2-9.
APA
Hagedorn, M., Delugin, M., Abraldes, I., Allain, N., Belaud-Rotureau, M.-A., Turmo, M., Prigent, C., Loiseau, H., Bikfalvi, A., & Javerzat, S. (2007). FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients. Cell Division, 2, 9. https://doi.org/10.1186/1747-1028-2-9
Chicago
Hagedorn, Martin, Maylis Delugin, Isabelle Abraldes, Nathalie Allain, Marc-Antoine Belaud-Rotureau, Michelle Turmo, Claude Prigent, Hugues Loiseau, Andréas Bikfalvi, and Sophie Javerzat. 2007. “FBXW7/HCDC4 Controls Glioma Cell Proliferation in Vitro and Is a Prognostic Marker for Survival in Glioblastoma Patients.” Cell Division 2 (February): 9. doi:10.1186/1747-1028-2-9.